FFX: System, Gastrointestinal Motility (Electrical)

Product code FFX, “System, Gastrointestinal Motility (Electrical)” in FDA's classification database, is a Class II device type under 21 CFR 876.1725 (gastrointestinal motility monitoring system), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 70 clearances under FFX, 22 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
FFX
Regulation
21 CFR 876.1725
Class
II
Panel
Gastroenterology, Urology
Clearances
70
Most recent
Sep 30, 2026
Median review, last 2 years
87 days
Third-party review
Eligible
Implant
No

What it covers

A gastrointestinal motility monitoring system is a device used to measure peristalic activity or pressure in the stomach or esophagus by means of a probe with transducers that is introduced through the mouth into the gastrointestinal tract. The device may include signal conditioning, amplifying, and recording equipment. This generic type of device includes the esophageal motility monitor and tube, the gastrointestinal motility (electrical) system, and certain accessories, such as a pressure transducer, amplifier, and external recorder.

The identification in 21 CFR 876.1725, gastrointestinal motility monitoring system. FDA gives FFX no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K262621Rapid Barostat Bag (RBB) Pump and Catheter SystemMui Scientific, Inc.Sep 30, 2026Special
K252605mcompass Anorectal Balloon Expulsion Catheter (RMD-003-001)Medspira, LLCDec 5, 2025Traditional
K240007Solar Compact (G4-1)Laborie Medical Technologies, Corp.May 6, 2024Traditional
K231861EndoflipTM 300 SystemCovidien, LLCJul 21, 2023Special
K223705EndoflipTM 300Covidien, LLCApr 14, 2023Traditional
K222000Transit-PelletsMedifactia ABJan 18, 2023Traditional
K201106IntraMarX 3D Radiopaque MarkerAnx Robotica CorpMay 21, 2020Special
K191087IntraMarX Radiopaque MarkersAnx Robotica CorpDec 18, 2019Traditional
K190208Diversatek Healthcare High Resolution Impedance Manometry (HRiM) ProbeDiversatek HealthcareOct 3, 2019Traditional
K181760Transit-PelletsMedifactia ABAug 8, 2019Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 70 with a free account)

Clearances by year

22 FFX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)164
20251109
20241125
20233123
2020127
20194240
20181136
20172217
20163145
20131107
20124120

Who submits

13 applicants cleared a FFX device since 2011. 50% of the clearances went to applicants in United States, then Canada (18%), Ireland (14%) and Sweden (9%). By type: Traditional 77% and Special 23%.

ApplicantClearances since 2011
Crospon, Ltd.5
Mui Scientific3
Anx Robotica Corp2
Covidien, LLC2
Medifactia AB2
Diversatek Healthcare1
Given Imaging , Ltd.1
Konsyl Pharmaceuticals1

How FDA classifies it

Class II (performance standards).

From 21 CFR 876.1725.

Standards

21 CFR 876.1725 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent FFX clearances declared.

Ask about FFX

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about FFX

What is FDA product code FFX?

Product code FFX, “System, Gastrointestinal Motility (Electrical)” in FDA's classification database, is a Class II device type under 21 CFR 876.1725 (gastrointestinal motility monitoring system), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 70 clearances under FFX, 22 of them since 2011.

How many 510(k) clearances are there under FFX?

FDA’s 510(k) database listed 70 clearances under FFX as of Oct 29, 2026, 22 of them decided since 2011; the most recent decision was Sep 30, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a FFX 510(k)?

For the 2 FFX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 87 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most FFX clearances?

Since 2011: Crospon, Ltd. (5), Mui Scientific (3), Anx Robotica Corp (2), Covidien, LLC (2) and Medifactia AB (2). 13 applicants have cleared a FFX device in that time.

Sources

  1. FDA product classification: FFX · Product Classification database
  2. 21 CFR 876.1725: Gastrointestinal motility monitoring system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for FFX · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow FFXGet an email when FDA clears, recalls or publishes guidance for FFX devices.

Know what FDA already cleared.